Notice of Meeting, 41400-41401 [05-14183]

Download as PDF 41400 Federal Register / Vol. 70, No. 137 / Tuesday, July 19, 2005 / Notices Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: 1. Marianne Boyd Johnson, Las Vegas, Nevada; to acquire approximately 22.4 percent of the voting shares of Western Alliance Bancorporation, Las Vegas, Nevada, and thereby indirectly acquire voting shares of BankWest of Nevada, Las Vegas, Nevada, Torrey Pines Bank, San Diego, California, and Alliance Bank of Arizona, Phoenix, Arizona. Board of Governors of the Federal Reserve System, July 13, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–14167 Filed 7–18–05; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM Change in Bank Control Notices, Acquisition of Shares of Bank or Bank Holding Companies; Correction This notice corrects a notice (FR Doc. 05-13519) published on pages 3977539776 for the issue for Monday, July 11, 2005. Under the Federal Reserve Bank of St. Louis heading, the entry for Charles Hardcastle, Bowling Green, Kentucky, is revised to read as follows: A. Federal Reserve Bank of St. Louis (Glenda Wilson, Community Affairs Officer) 411 Locust Street, St. Louis, Missouri 63166-2034: 1. Charles Anderson Hardcastle, Bowling Green, Kentucky, individually and as a member of the Hardcastle Control Group, which also includes Carolyn Hardcastle, Bowling Green, Kentucky; Colleen Hardcastle, Oakland, New Jersey; Cheryl Anderson; Patrick Anderson; Laura Anderson; and Erin Anderson; all of Lexington, Kentucky; to acquire voting shares of Citizens First Corporation, Bowling Green, Kentucky, and thereby indirectly acquire Citizens First Bank, Bowling Green, Kentucky. Comments on this application must be received by July 25, 2005. Board of Governors of the Federal Reserve System, July 13, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–14168 Filed 7–18–05; 8:45 am] BILLING CODE 6210–01–S VerDate jul<14>2003 17:15 Jul 18, 2005 Jkt 205001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency For Healthcare Research and Quality Dated: July 11, 2005. Carolyn M. Clancy, Director. [FR Doc. 05–14182 Filed 7–18–05; 8:45 am] BILLING CODE 4160–90–M Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Dissertation grant application, ‘‘The Economics of Mother’s Milk Feedings in the Neonatal Intensive Care Unit’’ is to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the application. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: The Economics of Mother’s Milk Feedings in the Neonatal Intensive Care Unit. Date: July 19, 2005 (open on July 19 from 1 p.m. to 1:15 p.m. and closed for the remainder of the telephone conference call meeting). Place: AHRQ, John M. Eisenberg Building, 540 Gaither Road, 2nd Floor Conference Room, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. This notice is being published less than 15 days prior to the July 19 meeting, due to the time constraints of reviews and funding cycles. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2) announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Announcement of Availability of Funds for Grants for Family Planning Service Delivery Improvement Research are to be reviewed and discussed at this meeting. This program is sponsored by the Office of Population Affairs. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Announcement of Availability of Funds for Grants for Family Planing Service Delivery Improvement Research. Date: August 9, 2005 (open on August 9 from 8:15 a.m. and closed for the remainder of the meeting). Place: John M. Eisenberg Building, AHRQ Conference Center, 540 Gaither Road, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room E:\FR\FM\19JYN1.SGM 19JYN1 Federal Register / Vol. 70, No. 137 / Tuesday, July 19, 2005 / Notices 2038, Rockville, Maryland 20850, telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: July 11, 2005. Carolyn M. Clancy, Director. [FR Doc. 05–14183 Filed 7–18–05; 8:45 am] BILLING CODE 4160–10–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Single Gene Disorders Resource Network Announcement Type: New. Funding Opportunity Number: AA092. Catalog of Federal Domestic Assistance Number: 93.283. Key Dates: Letter of Intent (LOI) Deadline: July 29, 2005. Application Deadline: August 18, 2005. I. Funding Opportunity Description Authority: This program is authorized under Sections 301, 311 and 317(C) of the Public Health Service Act [42 U.S.C. 241, 243, and 247b–4 as amended]. Background: There are over 6000 known single gene disorders, including over 1650 with identified genes. Single gene disorders occur in about one in 300 births, and account for 13 percent of inpatients in pediatric hospital and three to five percent of pediatric deaths. The National Center on Birth Defects and Developmental Disabilities (NCBDDD) seeks to ensure the optimal outcome of people with disabling or potential disabling pediatric single gene conditions and their families, by developing surveillance systems that meet challenges of single gene disorders, improving screening and diagnosis, and improving services to patients and families. Genetic disorders raise different issues for health care providers and families than do nongenetic disorders because genetic disorders have implications for other family members, and raise psychosocial issues (such as guilt, blame and stigmatization). Lessons learned from public health activities in single gene disorders can be applied to complex disorders as their etiologies become elucidated. This cooperative agreement will fund the development of a national resource network for single gene disorders. Initial funding will support projects related to Duchenne and Becker Muscular Dystrophy (DBMD) and Fragile X VerDate jul<14>2003 17:15 Jul 18, 2005 Jkt 205001 syndrome (FXS). The proposed National Network will have the capacity to expand to other single gene disorders. Purpose: The purpose of the program is to develop, implement, and evaluate a Network for Single Gene Disorders, focusing specifically on DBMD and FXS. This program addresses the ‘‘Healthy People 2010’’ focus areas of Disability and Secondary Conditions; Mental Health and Mental Health Disorders; and Maternal, Infant, and Child Health.’’. Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the National Center on Birth Defects and Developmental Disabilities (NCBDDD): Prevent birth defects and developmental disabilities, and improve the health and quality of life of Americans with disabilities. This announcement is only for nonresearch activities supported by CDC/ ATSDR. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/ads/ opspoll1.htm. Activities: Applicants may apply for funding under part A and/or part B. Please note that if applicants choose to apply for both part A and part B, applicants may submit consolidated applications addressing the requirements of both part A and part B under one application. Awardee activities for part A of this program are as follows: • Increase access to accurate and scientifically valid information on the etiology, diagnosis, and treatment of DBMD for end users including families, educators, health professionals, allied health caregivers, and the general public. The awardee will specifically assemble and/or develop informational materials that: (1) Reflect expert opinion, evidence-based knowledge and current clinical practice, and (2) respond to the needs of individuals and families affected by DBMD. These informational materials will be disseminated to the target populations. • Assess current educational and outreach materials related to DBMD targeted at families with DBMD and the general public. Develop and/or modify, implement and evaluate educational materials for families with DBMD and the general public, including information on the etiology, clinical course, treatment options, and available services (including services supported by Health Resources and Services Administration, the Administration for Children and Families/Administration on Developmental Disabilities, and PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 41401 other DHHS-supported efforts that target families of children with disabilities). Content of materials includes issues specific to single gene disorders, such as genetic counseling. • Assess current educational and outreach materials related to DBMD targeted at health care providers. Develop and/or modify, implement and evaluate educational materials for providers and students, focusing on recognition, diagnosis, referral and treatment. Content of materials includes current diagnostic and treatment standards or guidelines; and issues specific to single gene disorders, such as genetic counseling. • Disseminate the information on DBMD widely within the targeted group including families, educators, health professionals, allied health caregivers, and the general public. This may be new or existing materials in a variety of formats including written, video, CD, and World Wide Web. Ensure the dissemination plan for the materials is developed, methods for reaching underserved and minority communities are described and justified; and accurate information about diagnosis and treatment of DBMD is available to various stakeholders, i.e., practitioners, families, teachers, and other caregivers. • Coordinate educational activities with other community-based and community-wide providers and organizations that offer services or direct education messages to U.S. residents that have DBMD and their providers. • Hire and train staff as necessary to implement education and outreach activities for DBMD. • Increase opportunities for regular and ongoing DBMD training and education available to persons within the targeted audiences. • Identify core competencies about DBMD for medical and allied health students. • Evaluate the core competencies for appropriateness and validity based on needs of the audiences and on scientific research. • Develop methods to ensure that materials and resources for DBMD education and training are easily accessible. • Coordinate activities with other awardees. Awardee activities for part B of this program are as follows: • Increase access to accurate and scientifically valid information on the etiology, diagnosis, and treatment of FXS for end users including health professionals, allied health caregivers, and students. The awardee will specifically assemble and/or develop E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 70, Number 137 (Tuesday, July 19, 2005)]
[Notices]
[Pages 41400-41401]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-14183]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2) announcement is made of a Health Care Policy 
and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care research who are invited by the Agency for Healthcare 
Research and Quality (AHRQ), and agree to be available, to conduct on 
an as needed basis, scientific reviews of applications for AHRQ 
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of 
time. Rather, they are asked to participate in particular review 
meetings which require their type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the Announcement of Availability of 
Funds for Grants for Family Planning Service Delivery Improvement 
Research are to be reviewed and discussed at this meeting. This program 
is sponsored by the Office of Population Affairs. These discussions are 
likely to reveal personal information concerning individuals associated 
with the applications. This information is exempt from mandatory 
disclosure under the above-cited statutes.

    SEP Meeting on: Announcement of Availability of Funds for Grants 
for Family Planing Service Delivery Improvement Research.
    Date: August 9, 2005 (open on August 9 from 8:15 a.m. and closed 
for the remainder of the meeting).
    Place: John M. Eisenberg Building, AHRQ Conference Center, 540 
Gaither Road, Rockville, Maryland 20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the non-confidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room

[[Page 41401]]

2038, Rockville, Maryland 20850, telephone (301) 427-1554.

    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: July 11, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-14183 Filed 7-18-05; 8:45 am]
BILLING CODE 4160-10-M